George Soros Soros Fund Management
George Soros is the founder of Soros Fund Management and one of the most famous macro investors in modern markets. He is best known for large global bets informed by his theory of reflexivity, including the 1992 sterling trade. Though the firm later evolved as a family office, its equity filings and historical track record remain a reference point for students of macro and activist-era hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.5M |
| 2 |
Aramark
ARMK
|
+$46.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$39.3M |
| 4 |
Okta
OKTA
|
+$39.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$241M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$239M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$90.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$82.4M |
| 5 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$65.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.64% |
| 2 | Industrials | 7.12% |
| 3 | Financials | 5.45% |
| 4 | Communication Services | 5.11% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
MP Materials
MP
$10.7B
| $8.37M | 0.14% |
+585,209
| New | +$9.26M |
|
102
Sixth Street Specialty
TSLX
$1.79B
| $7.93M | 0.13% |
+370,000
| New | +$7.95M |
|
|
AAMI
103
Acadian Asset Management
AAMI
$3.28B
| $7.91M | 0.13% |
346,293
| – | – |
|
104
Edwards Lifesciences
EW
$51.8B
| $7.17M | 0.12% |
+75,000
| New | +$6.3M |
|
105
Kosmos Energy
KOS
$1.76B
| $7.15M | 0.12% |
+1,200,409
| New | +$7.22M |
|
106
DexCom
DXCM
$34.8B
| $6.93M | 0.12% |
50,000
-60,000
| -55% | -$7.54M |
|
107
JPMorgan Chase
JPM
$935B
| $6.91M | 0.11% |
+34,500
| New | +$6.23M |
|
108
Invesco QQQ Trust
QQQ
$486B
| $6.66M | 0.11% |
+15,000
| New | +$6.43M |
|
|
AY
109
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $6.47M | 0.11% |
350,000
| – | – |
|
110
Pacific Biosciences
PACB
$420M
| $6.12M | 0.1% |
+1,633,000
| New | +$9.56M |
|
111
Natera
NTRA
$47.9B
| $5.94M | 0.1% |
65,000
-85,000
| -57% | -$6.39M |
|
112
Qualcomm
QCOM
$169B
| $5.93M | 0.1% |
35,000
+5,000
| +17% | +$773K |
|
113
Hamilton Insurance Group
HG
$3.45B
| $5.69M | 0.09% |
408,634
-112,841
| -22% | -$1.64M |
|
114
DuPont de Nemours
DD
$18.7B
| $5.58M | 0.09% |
+58,001
| New | +$5.16M |
|
115
Corebridge Financial
CRBG
$14.2B
| $5.57M | 0.09% |
194,000
-35,000
| -15% | -$864K |
|
116
Enterprise Products Partners
EPD
$82.1B
| $5.54M | 0.09% |
190,000
| – | – |
|
117
First Citizens BancShares
FCNCA
$24.7B
| $5.45M | 0.09% |
3,333
| – | – |
|
118
CALL
Unity
U
$20.7B
| $5.34M | 0.09% |
200,000
-400,000
| -67% | -$12.6M |
|
119
3M
MMM
$92.3B
| $5.3M | 0.09% |
+59,800
| New | +$4.96M |
|
120
GE Aerospace
GE
$361B
| $5.27M | 0.09% |
+37,590
| New | +$4.43M |
|
|
SAGE
121
DELISTED
Sage Therapeutics
SAGE
| $5.15M | 0.09% |
+275,000
| New | +$6.34M |
|
|
BBOT
122
BridgeBio Oncology
BBOT
$728M
| $4.94M | 0.08% |
+475,000
| New | +$4.92M |
|
123
Carrier Global
CARR
$49.8B
| $4.92M | 0.08% |
+84,716
| New | +$4.76M |
|
124
TSMC
TSM
$2.17T
| $4.63M | 0.08% |
34,047
-45,953
| -57% | -$5.71M |
|
125
Privia Health
PRVA
$2.7B
| $4.41M | 0.07% |
225,000
+25,000
| +13% | +$528K |
|
Similar funds
George Soros's Q1 2024 Portfolio in Review
As of Q1 2024, George Soros held 274 positions worth $6.02B, down 21% from $7.65B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
George Soros withdrew a net $2.86B in Q1 2024, closing 81 positions and reducing 34 holdings. Its most notable exit was Splunk Inc, an estimated $241M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5% a quarter earlier, followed by Industrials and Financials.
Against the trend, George Soros opened a new position in Cerevel Therapeutics Holdings, Inc. Common Stock worth $82M.
- George Soros's largest Q1 2024 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 1,940,201 shares worth $82M.
- George Soros added most to Aramark in Q1 2024, an estimated $46.4M increase.
- George Soros's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $90.1M.
- George Soros fully exited Splunk Inc in Q1 2024, selling an estimated $241M.
- George Soros's ten largest holdings make up 30% of its $6.02B portfolio in Q1 2024.
- George Soros opened 78 new positions and closed 81 in Q1 2024.
- George Soros's portfolio value fell 21% quarter-over-quarter to $6.02B.
Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.